Connection

Evangelos Terpos to Peptides

Back to Details
This is a "connection" page, showing publications Evangelos Terpos has written about Peptides.
Evangelos Terpos
Connection Strength
0.078
Peptides
  1. Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. Blood Adv. 2018 11 13; 2(21):2837-2847.
    View in: PubMed
    Score: 0.078
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.